BRITTANY PALMER: Open Payments
NPI 1790142271 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$578 in 33 payments from 14 companies in 2025. Trend: 2023 $737 · 2024 $964 · 2025 $578
Food & beverage: $578
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 13 | $205 |
| Amgen Inc. | 4 | $69 |
| Lilly USA, LLC | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 2 | $37 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Verona Pharma, Inc. | 1 | $25 |
| Corium, LLC | 2 | $25 |
| Exact Sciences Corporation | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 1 | $22 |
| Eisai Inc. | 1 | $20 |
Products named: Wegovy, Rybelsus, EVENITY, MOUNJARO, FARXIGA, TZIELD, Ohtuvayre, Azstarys.
Industry payments across GA — which companies pay providers there.
